Drug Type Small molecule drug |
Synonyms SK channel opener (Ataxion) |
Target |
Action inhibitors |
Mechanism KCNN2 inhibitors(potassium calcium-activated channel subfamily N member 2 inhibitors), KCa2.3 inhibitors(potassium calcium-activated channel subfamily N member 3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Ataxia | Discovery | United States | - |